Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Cancer|March 15, 1981
Methotrexate: an active drug in bladder cancerR B Natale, A Yagoda, R C Watson, et al.American Journal of Clinical Oncology|August 1, 1984
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumorsG J Bosl, A Yagoda, W F Whitmore, et al.American Journal of Clinical Oncology|April 1, 1982
Phase II trials of methylglyoxal-bis (guanylhydrazone)D P Kelsen, A Yagoda, R Warrell, et al.Cancer|February 1, 1976
Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycinR E Wittes, A Yagoda, O Silvay, et al.Investigational New Drugs|June 17, 2000
A phase II pilot study of KW-2189 in patients with advanced renal cell carcinomaE J Small, R Figlin, D Petrylak, et al.Cancer Treatment Reports|October 1, 1987
Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnoverH I Scher, T Curley, N Geller, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable diseaseH I Scher, C Sternberg, W D Heston, et al.Cancer Research|January 1, 1984
Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory studyD M Moccio, F M Sirotnak, L L Samuels, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activityZ Khaled, D Rideout, K R O'Driscoll, et al.The American Journal of Medicine|March 1, 1985
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsG J Bosl, A Yagoda, R B Golbey, et al.Pageof 10